Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: May 2009
-
Law Seminars International (LSI) will be holding a one-day seminar entitled "Buying, Selling and Licensing Patents: Strategies for Turning Your Patent Portfolios into Revenue Streams" on July 20, 2009 in Washington, DC. During the seminar, LSI's faculty will offer presentations on the following topics: • Patent marketplace 2009 and beyond;• Patent sales case studies;• Patent…
-
The American Bar Association (ABA) will be holding its 2009 Annual Meeting from July 30 to August 4, 2009 in Chicago, IL. During the Annual Meeting, various ABA sections and divisions will be offering more than 250 CLE programs, including the following programs that will be offered by the Intellectual Property Law section: • Patent…
-
By Donald Zuhn — On Wednesday, we posted a report on a BIO Super Session entitled "A Model Patent Office for the Future — Promoting and Protecting Investments in Innovation" (see "Docs at BIO: Panel Offers Suggestions for Fixing the USPTO"). At that session, a panel consisting of Sherry Knowles (at right), Vice President…
-
By Suresh Pillai — Bavarian Nordic Suit over TroVax® Survives Motion to Dismiss Last week, the U.S. District Court for the Southern District of California refused to dismiss an amended complaint filed by Bavarian Nordic A/S alleging that Oxford Biomedica infringes Bavarian Nordic's U.S. Patent Nos. 6,761,893, 6,913,752, 7,335,364, and 7,459,270 with respect to…
-
By Donald Zuhn — In a Wednesday Super Session entitled "A Model Patent Office for the Future — Promoting and Protecting Investments in Innovation," a panel consisting of Sherry Knowles, Vice President of Corporate Intellectual Property at GlaxoSmithKline Biopharmaceuticals, Inc.; Q. Todd Dickinson, Executive Director for the American Intellectual Property Law Association (AIPLA); John…
-
By Kevin E. Noonan — What a difference a year makes. Steven Burrill (at right), President and CEO of Burrill & Co., unveiled his company's "State of the Biotechnology Industry" report on Tuesday at BIO 2009 in Atlanta. Mr. Burrill described what he termed "a sea change" that has occurred over the past several…
-
By Donald Zuhn — In a Breakout Session entitled "The Emerging Promise of Personalized Medicine," a panel consisting of Cindy Collins, Group Vice President at Beckman Coulter, Inc.; Brian Barrett, Associate General Patent Counsel at Eli Lilly & Company; Dr. Courtney Harper, Associate Director for Toxicology at the Office of In Vitro Diagnostic Device…
-
By Sherri Oslick — In a Super Session held Tuesday morning at the BIO 2009 conference, Ernst & Young hosted "Beyond Borders — Ernst & Young's Global Biotechnology Report 2009," a presentation that summarized the financial performance of the biotechnology industry in 2008 and addressed related issues and trends. The session consisted of brief…
-
By Kevin E. Noonan — In an otherwise unremarkable decision affirming the district court's claim construction and summary judgment of noninfringement in Abbott Laboratories v. Sandoz, Inc., the Court of Appeals for the Federal Circuit took the opportunity to reconcile a long-standing conflict in its precedent. Deciding this portion en banc, the court expressly…
-
The Biotechnology Industry Organization (BIO) is holding its annual BIO International Convention this week at the Georgia World Congress Center in Atlanta. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,200 biotechnology companies, state and international affiliates, and related organizations, as well as providing business development…
Patent Docs 